undamentalytics Newsletter
Sign in

Lemaitre Vascular Inc cash flow statement

In fiscal 2025, Lemaitre Vascular Inc's operations generated $81.3m of cash; it spent $6.8m on capital projects, leaving free cash flow of $74.5m. It returned $18.1m in dividends and $1.8m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations573556111723201435352537448183
Depreciation and amortisation11223334445811910101011
Stock-based pay111111122233345788
Capital spending122131236343537779
Free cash flow55143491416161032302229377474
Free cash flow after stock pay4402138121414829271824316766
Dividends paid——122233457891112141820
Share buybacks132200001111111222
Shares issued000011151635663366——

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: KIDS vs LMATAXGN vs LMATCERS vs LMATESTA vs LMAT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lemaitre Vascular Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lemaitre Vascular Inc.